Merck & Co., Inc. (MRK) Reports In-Line Q2 EPS of 95c; Raises Low End of FY11 Guidance Range
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $146.87 -0.19%
EPS Growth %: -14.0%
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -14.0%
Financial Fact:
Total Costs, Expenses and Other: 12.82B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Merck & Co., Inc. (NYSE: MRK) reported Q2 EPS of $0.95, in-line with the analyst estimate of $0.95. Revenue for the quarter came in at $12.2 billion versus the consensus estimate of $11.78 million.
To cut workforce by added 12-13% by end of 2015.
Raises the lower end of its FY11 EPS range to $3.68-$3.76, the Street is currently looking for EPS of $3.74.
To cut workforce by added 12-13% by end of 2015.
Raises the lower end of its FY11 EPS range to $3.68-$3.76, the Street is currently looking for EPS of $3.74.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Fluence Energy cuts fiscal 2026 revenue outlook on supply chain woes
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
